BnO-PEG5-CH2CH2NH2 manufacturers
- Benzyl-PEG6-NH2
-
-
2025-06-07
- CAS:86770-78-7
- Min. Order: 1g
- Purity: >97.00%
- Supply Ability: 1g
|
| | BnO-PEG5-CH2CH2NH2 Basic information |
| Product Name: | BnO-PEG5-CH2CH2NH2 | | Synonyms: | BnO-PEG5-CH2CH2NH2;2,5,8,11,14,17-Hexaoxanonadecan-19-amine, 1-phenyl-;H2N-(CH2CH2O)6-Bn;BnO-PEG5-CH2CH2NH2/2,5,8,11,14,17-Hexaoxanonadecan-19-amine, 1-phenyl-;1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-amine;BnO-PEG6-NH2 | | CAS: | 86770-78-7 | | MF: | C19H33NO6 | | MW: | 371.47 | | EINECS: | | | Product Categories: | | | Mol File: | 86770-78-7.mol |  |
| | BnO-PEG5-CH2CH2NH2 Chemical Properties |
| Boiling point | 466.8±40.0 °C(Predicted) | | density | 1.074±0.06 g/cm3(Predicted) | | storage temp. | Store at Room Tem. | | pka | 8.74±0.10(Predicted) |
| | BnO-PEG5-CH2CH2NH2 Usage And Synthesis |
| Uses | Benzyl-PEG6-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | BnO-PEG5-CH2CH2NH2 Preparation Products And Raw materials |
|